Insider · CIK 0001664852
Scott Requadt
Files at EPIX (ESSA Pharma Inc.). First filing -, latest -.
Scott Requadt files SEC Form 4 as director at EPIX (ESSA Pharma Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Scott Requadt has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 9, 2025 | EPIX ESSA Pharma Inc. | DDisposition to issuer Common Shares | -30,002 | - | - | 0 | Oct 15, 2025 |
Questions about Scott Requadt
Answered from the filings on this page, as of the latest one.
Is Scott Requadt buying or selling?
Scott Requadt has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Scott Requadt's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Scott Requadt has 0.
Where does Scott Requadt file Form 4?
Scott Requadt has filed Form 4 at EPIX (ESSA Pharma Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.